ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

PHAT Phathom Pharmaceuticals Inc

11.089
0.139 (1.27%)
14 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Phathom Pharmaceuticals Inc PHAT NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.139 1.27% 11.089 23:00:01
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
10.73 10.66 11.40 11.35 10.95
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
14/6/202415:05EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
14/6/202415:05EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
06/6/202412:59EDGAR2Form SC 13D/A - General statement of acquisition of..
31/5/202417:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202407:00GLOBEPhathom Pharmaceuticals to Participate in Upcoming Investor..
24/5/202418:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202415:03EDGAR2Form 8-K - Current report
15/5/202407:00GLOBEPhathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan)..
09/5/202415:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202407:05EDGAR2Form 8-K - Current report
09/5/202407:00GLOBEPhathom Pharmaceuticals Reports First Quarter 2024 Financial..
29/4/202407:00GLOBEPhathom Pharmaceuticals to Report First Quarter 2024..
03/4/202407:00GLOBEPhathom Pharmaceuticals to Participate in the 23rd Annual..
26/3/202407:00GLOBEPhathom Pharmaceuticals Launches Direct-to-Consumer..
07/3/202415:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/3/202407:06EDGAR2Form 8-K - Current report
07/3/202407:00GLOBEPhathom Pharmaceuticals Reports Fourth Quarter and Full Year..
29/2/202407:00GLOBEPhathom Pharmaceuticals to Report Fourth Quarter and Full..
13/2/202407:05EDGAR2Form 8-K - Current report
13/2/202407:00GLOBEPhathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan)..
31/1/202407:00GLOBEPhathom Pharmaceuticals to Present at the Guggenheim..
22/1/202419:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202315:05EDGAR2Form 8-K - Current report
14/12/202307:05EDGAR2Form 8-K - Current report
14/12/202307:00GLOBEPhathom Pharmaceuticals Announces Expansion of Existing Loan..
06/12/202307:05EDGAR2Form 8-K - Current report
06/12/202307:00GLOBEPhathom Pharmaceuticals Announces FDA Acceptance for Filing..
28/11/202307:06EDGAR2Form 8-K - Current report
28/11/202307:00GLOBEPhathom Pharmaceuticals Announces Commercial Availability of..
19/11/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
09/11/202315:02EDGAR2Form S-3 - Registration statement under Securities Act of..
09/11/202307:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202307:05EDGAR2Form 8-K - Current report
09/11/202307:00GLOBEPhathom Pharmaceuticals Reports Third Quarter 2023 Results..
08/11/202318:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202315:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202316:50DJNPhathom Pharmaceuticals Gets FDA Approval for Voquezna..
01/11/202316:06EDGAR2Form 8-K - Current report
01/11/202316:00GLOBEPhathom Pharmaceuticals Announces FDA Approval of VOQUEZNA®..
30/10/202307:05EDGAR2Form 8-K - Current report
30/10/202307:00GLOBEPhathom Pharmaceuticals Announces FDA Approval of..
25/10/202307:01GLOBEPhathom Pharmaceuticals to Participate in Upcoming Investor..
26/9/202307:05EDGAR2Form 8-K - Current report
26/9/202307:01GLOBEPhathom Pharmaceuticals Announces Vonoprazan NDA Submission..
05/9/202307:00GLOBEPhathom Pharmaceuticals to Participate in Upcoming Investor..
21/8/202307:07EDGAR2Form 8-K - Current report
21/8/202307:00GLOBEPhathom Pharmaceuticals Announces Submission of Six-Month..
10/8/202315:02EDGAR2Form 8-K - Current report
10/8/202307:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202307:01GLOBEPhathom Pharmaceuticals Reports Second Quarter 2023 Results

Su Consulta Reciente

Delayed Upgrade Clock